What's in AJU Pharm Co., Ltd.'s pipeline?

AJU Pharm Co., Ltd. has 18 drugs in our index: 3 marketed, 0 filed, 7 in Phase 3, 0 in Phase 2, 8 in Phase 1.

Which companies overlap with AJU Pharm Co., Ltd.'s portfolio?

Top competitors by shared drug class: Daewon Pharmaceutical Co., Ltd., Pfizer, Avalo Therapeutics, Inc., Chia Tai Tianqing Pharmaceutical Group Co., Ltd., Daewoong Pharmaceutical Co. LTD..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/aju-pharm-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

AJU Pharm Co., Ltd. — Portfolio Competitive Intelligence Brief

AJU Pharm Co., Ltd. pipeline: 3 marketed, 0 filed, 7 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 7 Phase 3 0 Phase 2 8 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
B55R1 and placebo for B55R2	B55R1 and placebo for B55R2	marketed	small molecule	unknown	Cardiovascular
OM-89 [Uro-Vaxom® Capsule]	OM-89 [Uro-Vaxom® Capsule]	marketed
B55R1 and B55R2	B55R1 and B55R2	marketed	SGLT2 inhibitor	SGLT2	Diabetes
AJU-C52L, AJU-C52	AJU-C52L, AJU-C52	phase 3
AJU-A51	AJU-A51	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
C52R1L, C52R1M	C52R1L, C52R1M	phase 3
A51R3	A51R3	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
Placebo Group(Vehicle)	Placebo Group(Vehicle)	phase 3
A51R2	A51R2	phase 3
AJU-S56 5%	AJU-S56 5%	phase 3	SGLT2 inhibitor	SGLT2	Diabetes

Therapeutic area mix

Diabetes · 4
Cardiovascular · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Daewon Pharmaceutical Co., Ltd. · 2 shared drug classes
Pfizer · 2 shared drug classes
Avalo Therapeutics, Inc. · 2 shared drug classes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · 2 shared drug classes
Daewoong Pharmaceutical Co. LTD. · 2 shared drug classes
Health Ever Bio-Tech Co., Ltd. · 2 shared drug classes
Ahn-Gook Pharmaceuticals Co.,Ltd · 2 shared drug classes
Pharmbio Korea Co., Ltd. · 2 shared drug classes

Subscribe to ongoing alerts

Every new pipeline event for AJU Pharm Co., Ltd.:

Cite this brief

Drug Landscape (2026). AJU Pharm Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/aju-pharm-co-ltd. Accessed 2026-05-16.